NDC Active Ingredient Axitinib

Active Ingredient Information

What is Axitinib?

A benzamide and indazole derivative that acts as a TYROSINE KINASE inhibitor of the VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR. It is used in the treatment of advanced RENAL CELL CARCINOMA.

What is the usage for Axitinib?

This medication is used to treat kidney cancer. Axitinib works by slowing or stopping the growth of cancer cells. It belongs to a class of drugs known as tyrosine kinase inhibitors.

How many products in the NDC database contain Axitinib?

The NDC database has 9 products with the active ingredient Axitinib. The following table lists all the products that have this active ingredient.

NDC Products with Axitinib

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Company Name Status
0069-0145Proprietary Name: Inlyta AxitinibTablet, Film CoatedOralPfizer Laboratories Div Pfizer IncACTIVE
0069-0151Proprietary Name: Inlyta AxitinibTablet, Film CoatedOralPfizer Laboratories Div Pfizer IncACTIVE
54893-0032Proprietary Name: AxitinibPowderMsn Laboratories Private LimitedACTIVE
54893-0043Proprietary Name: AxitinibPowderMsn Laboratories Private LimitedACTIVE
63539-026Proprietary Name: Inlyta AxitinibTablet, Film CoatedOralU.s. PharmaceuticalsACTIVE
63539-044Proprietary Name: Inlyta AxitinibTablet, Film CoatedOralU.s. PharmaceuticalsACTIVE
65344-0033Proprietary Name: AxitinibPowderZhejiang Jiuzhou Pharmaceutical Co., Ltd.ACTIVE
68554-0088Proprietary Name: AxitinibPowderHetero Labs LimitedACTIVE
82920-028Proprietary Name: AxitinibPowderShilpa Pharma Lifesciences LimitedACTIVE
<